Skip to main content
. 2020 Sep 15;202(6):866–877. doi: 10.1164/rccm.201912-2489OC

Figure 3.

Figure 3.

Rifapentine autoinduction profile. (A) The sigmoid relationship between rifapentine concentration and autoinduction is shown with the solid black line. Dashed lines represent the average concentration at a steady state of daily therapy with 300, 450, and 600 mg of rifapentine in a typical HIV-negative individual. (B) Rifapentine induction over time after daily administration of 600 mg. The black dashed line represents the time at which the induction process reaches a steady state.